532 related articles for article (PubMed ID: 33427197)
1. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
2. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
3. Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution.
Van den Eynden J; Basu S; Larsson E
PLoS Genet; 2016 Dec; 12(12):e1006506. PubMed ID: 28027311
[TBL] [Abstract][Full Text] [Related]
4. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
5. Cancer heterogeneity: converting a limitation into a source of biologic information.
Rübben A; Araujo A
J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
[TBL] [Abstract][Full Text] [Related]
6. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
7. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
[TBL] [Abstract][Full Text] [Related]
8. [Current topics in mutations in the cancer genome].
Iwaya T; Mimori K; Wakabayashi G
Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):185-90. PubMed ID: 22582578
[TBL] [Abstract][Full Text] [Related]
9. Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution.
Wodarz D; Newell AC; Komarova NL
J R Soc Interface; 2018 Jun; 15(143):. PubMed ID: 29875280
[TBL] [Abstract][Full Text] [Related]
10. Universal Patterns of Selection in Cancer and Somatic Tissues.
Martincorena I; Raine KM; Gerstung M; Dawson KJ; Haase K; Van Loo P; Davies H; Stratton MR; Campbell PJ
Cell; 2017 Nov; 171(5):1029-1041.e21. PubMed ID: 29056346
[TBL] [Abstract][Full Text] [Related]
11. Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.
Youn A; Simon R
BMC Bioinformatics; 2013 Dec; 14():363. PubMed ID: 24330428
[TBL] [Abstract][Full Text] [Related]
12. A latent variable model for evaluating mutual exclusivity and co-occurrence between driver mutations in cancer.
Shuaibi A; Chitra U; Raphael BJ
bioRxiv; 2024 Apr; ():. PubMed ID: 38712136
[TBL] [Abstract][Full Text] [Related]
13. Identification of cancer driver genes based on nucleotide context.
Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
15. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
16. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
[TBL] [Abstract][Full Text] [Related]
17. Impact of accumulated alterations in driver and passenger genes on response to radiation therapy.
Seo Y; Tamari K; Takahashi Y; Minami K; Isohashi F; Suzuki O; Sumida I; Ogawa K
Br J Radiol; 2020 May; 93(1109):20190625. PubMed ID: 32031414
[TBL] [Abstract][Full Text] [Related]
18. Cancer initiation with epistatic interactions between driver and passenger mutations.
Bauer B; Siebert R; Traulsen A
J Theor Biol; 2014 Oct; 358():52-60. PubMed ID: 24859427
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.
Boström M; Larsson E
Nat Commun; 2022 Nov; 13(1):7023. PubMed ID: 36396655
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
